Reversine

Reversine is an antagonist of Adenosine Receptors and AURKA and related targets used in studies of Cell Cycle Regulation and GPCR Signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to checkpoint control, mitotic progression, and proliferation timing and receptor-driven second-messenger signaling and desensitization dynamics in cancer, cardiovascular, and cell cycle models.

By blocking Adenosine Receptors and AURKA and related targets, Reversine can be used to examine checkpoint control, mitotic progression, and proliferation timing and receptor-driven second-messenger signaling and desensitization dynamics. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cardiovascular, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Adenosine Receptors and AURKA and related targets
• Pathway perturbation studies connected to Cell Cycle Regulation and GPCR Signaling
• Receptor-blockade and ligand-competition studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, Reversine is appropriate when a defined chemical perturbant is needed to connect Adenosine Receptors and AURKA and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cardiovascular, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.